Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306291315> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4306291315 abstract "Abstract Pulmonary arterial hypertension (PAH), is a chronic disorder characterized by excessive pulmonary vascular remodelling, resulting in elevated pulmonary vascular resistance and right ventricle (RV) overload and failure. PAH remains incurable, and new therapeutic approaches are required. The microRNA-146a (miR-146a) promotes vascular smooth muscle cell proliferation and vascular neointimal hyperplasia, both important hallmarks of PAH. This study aimed to investigate the role of miR-146a in the pathophysiology of PAH and in the progression to RV hypertrophy and failure. Sprague Dawley rats received a subcutaneous injection of monocrotaline (MCT group) or vehicle (CTRL group) and, after fourteen days they were treated, by intratracheal nebulization, with an anti-miR-146a, forming four distinct groups: CTRL-treated; CTRL-untreated, MCT-treated, and MCT-untreated. Twenty-seven days after MCT injection, echocardiographic and invasive hemodynamic evaluations were performed in all animal groups. Also, wild-type (WT) and miR-146a knock-out (KO) (miR-146a−/−) mice were submitted to either 3 weeks of chronic hypoxia-induced PAH with weekly Sugen 5416 administration (SuHx). Compared to MCT-untreated rats, the MCT-treated rats showed decreased RV hypertrophy, (as measured by the Fulton index),decreased RV end-diastolic diameter/left ventricle end-diastolic diameter (RVEDD/LVEDD) ratio, and decreased in RV diastolic pressures. KO-SuHx group, when compared to WT-SuHx group, showed decreased RV hypertrophy (as measured by the Fulton index), and decreased RV systolic pressures and dilation, as well as lower RV end end-diastolic diameter (RVEDDi) and right atria area (RAAi). Our findings show that miR-146a pharmacological or genetic inhibition reduces RV remodelling and improves cardiac function. Thus, miR-146a represents a promising therapeutic target in PAH. Funding Acknowledgement Type of funding sources: Foundation. Main funding source(s): This research was supported by the Portuguese Foundation for Science and Technology (FCT)." @default.
- W4306291315 created "2022-10-15" @default.
- W4306291315 creator A5007363674 @default.
- W4306291315 creator A5031784500 @default.
- W4306291315 creator A5039151849 @default.
- W4306291315 creator A5052974638 @default.
- W4306291315 creator A5063133041 @default.
- W4306291315 creator A5081928203 @default.
- W4306291315 creator A5089713443 @default.
- W4306291315 date "2022-10-01" @default.
- W4306291315 modified "2023-10-13" @default.
- W4306291315 title "Therapeutic effects of nebulization-based delivery of anti-miR-146a in experimental pulmonary arterial hypertension" @default.
- W4306291315 doi "https://doi.org/10.1093/eurheartj/ehac544.2929" @default.
- W4306291315 hasPublicationYear "2022" @default.
- W4306291315 type Work @default.
- W4306291315 citedByCount "0" @default.
- W4306291315 crossrefType "journal-article" @default.
- W4306291315 hasAuthorship W4306291315A5007363674 @default.
- W4306291315 hasAuthorship W4306291315A5031784500 @default.
- W4306291315 hasAuthorship W4306291315A5039151849 @default.
- W4306291315 hasAuthorship W4306291315A5052974638 @default.
- W4306291315 hasAuthorship W4306291315A5063133041 @default.
- W4306291315 hasAuthorship W4306291315A5081928203 @default.
- W4306291315 hasAuthorship W4306291315A5089713443 @default.
- W4306291315 hasBestOaLocation W43062913151 @default.
- W4306291315 hasConcept C10162356 @default.
- W4306291315 hasConcept C126322002 @default.
- W4306291315 hasConcept C164705383 @default.
- W4306291315 hasConcept C167414201 @default.
- W4306291315 hasConcept C178853913 @default.
- W4306291315 hasConcept C2778198053 @default.
- W4306291315 hasConcept C2778271984 @default.
- W4306291315 hasConcept C2778921608 @default.
- W4306291315 hasConcept C2779376020 @default.
- W4306291315 hasConcept C2780930700 @default.
- W4306291315 hasConcept C2780940725 @default.
- W4306291315 hasConcept C3018791406 @default.
- W4306291315 hasConcept C57900726 @default.
- W4306291315 hasConcept C58245268 @default.
- W4306291315 hasConcept C71924100 @default.
- W4306291315 hasConcept C84393581 @default.
- W4306291315 hasConceptScore W4306291315C10162356 @default.
- W4306291315 hasConceptScore W4306291315C126322002 @default.
- W4306291315 hasConceptScore W4306291315C164705383 @default.
- W4306291315 hasConceptScore W4306291315C167414201 @default.
- W4306291315 hasConceptScore W4306291315C178853913 @default.
- W4306291315 hasConceptScore W4306291315C2778198053 @default.
- W4306291315 hasConceptScore W4306291315C2778271984 @default.
- W4306291315 hasConceptScore W4306291315C2778921608 @default.
- W4306291315 hasConceptScore W4306291315C2779376020 @default.
- W4306291315 hasConceptScore W4306291315C2780930700 @default.
- W4306291315 hasConceptScore W4306291315C2780940725 @default.
- W4306291315 hasConceptScore W4306291315C3018791406 @default.
- W4306291315 hasConceptScore W4306291315C57900726 @default.
- W4306291315 hasConceptScore W4306291315C58245268 @default.
- W4306291315 hasConceptScore W4306291315C71924100 @default.
- W4306291315 hasConceptScore W4306291315C84393581 @default.
- W4306291315 hasIssue "Supplement_2" @default.
- W4306291315 hasLocation W43062913151 @default.
- W4306291315 hasOpenAccess W4306291315 @default.
- W4306291315 hasPrimaryLocation W43062913151 @default.
- W4306291315 hasRelatedWork W2000114681 @default.
- W4306291315 hasRelatedWork W2070867241 @default.
- W4306291315 hasRelatedWork W2079561906 @default.
- W4306291315 hasRelatedWork W2156837129 @default.
- W4306291315 hasRelatedWork W2392333737 @default.
- W4306291315 hasRelatedWork W2409871230 @default.
- W4306291315 hasRelatedWork W2885384177 @default.
- W4306291315 hasRelatedWork W2922223128 @default.
- W4306291315 hasRelatedWork W3148516409 @default.
- W4306291315 hasRelatedWork W4244201864 @default.
- W4306291315 hasVolume "43" @default.
- W4306291315 isParatext "false" @default.
- W4306291315 isRetracted "false" @default.
- W4306291315 workType "article" @default.